← All companies

DNA

Ginkgo Bioworks Holdings, Inc.

DNA NYSE Biological Products, (No Diagnostic Substances) EDGAR ↗

$8.94

+0.85 +10.51%

Key statistics

from XBRL data in SEC filings

Market cap

-$977M

Revenue (TTM)

$151M

Net income (TTM)

$8.06M

EPS (TTM)

$-5.35

P/E ratio

—

Dividend yield

—

Free cash flow

-$179M

Cash

$144M

Total assets

$1.03B

Gross margin

—

52-week range

$5.37 – $17.58

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Regulation FD disclosure Jul 30, 2026 8-K Shareholder vote results Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Completed an acquisition or disposition Apr 7, 2026 8-K Entered a material agreement Feb 27, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change; Other events Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Entered a material agreement Sep 4, 2025 8-K Other events Aug 29, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Director or officer change; Regulation FD disclosure May 21, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Director or officer change Nov 12, 2024 8-K Delisting notice or listing-rule failure; Other events Sep 4, 2024 8-K Amended charter or bylaws Aug 19, 2024 8-K Shareholder vote results; Other events Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K/A Results of operations (earnings release); Exit or disposal costs Aug 8, 2024 8-K/A Exit or disposal costs Jun 24, 2024 8-K Shareholder vote results Jun 14, 2024 8-K Delisting notice or listing-rule failure; Regulation FD disclosure May 13, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Exit or disposal costs May 9, 2024 8-K Changed accountants Mar 14, 2024 10-K Fiscal year ended 2023-12-31 Feb 29, 2024 8-K Results of operations (earnings release) Feb 29, 2024 8-K Results of operations (earnings release) Jan 10, 2024 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Amended charter or bylaws Oct 27, 2023